Please use this identifier to cite or link to this item:
http://library.ediindia.ac.in:8181/xmlui//handle/123456789/8966
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gujarat State Biotechnology Mission | |
dc.date.accessioned | 2019-07-14T08:29:06Z | |
dc.date.available | 2019-07-14T08:29:06Z | |
dc.date.issued | 2006 | |
dc.identifier.uri | http://library.ediindia.ac.in:8181/xmlui//handle/123456789/8966 | |
dc.language.iso | en | en_US |
dc.publisher | Gujarat Department of Science and Technology | en_US |
dc.subject | T-cell receptors (TCR) | en_US |
dc.subject | CD3 | en_US |
dc.subject | MAGE-A1 and gp100 | en_US |
dc.subject | Epstein-Barr viral antigens EBNA-3A1B and BMLF-1 | en_US |
dc.subject | cancer immunotherapy | en_US |
dc.subject | Gene Transfer & Therapeutics | en_US |
dc.subject | Pharmaceutical and Healthcare | en_US |
dc.subject | GSBTM | en_US |
dc.title | Development of Receptors to Optimally Retarget Human T-cells to MHe-restricted Tumor or Viral Antigens. | en_US |
dc.type | Other | en_US |
Appears in Collections: | Vol. III - Pharmaceutical and Healthcare |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
3-114.pdf Restricted Access | 1.04 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.